Successful reconstitution of human hematopoiesis in the SCID-hu mouse by genetically modified, highly enriched progenitors isolated from fetal liver

Blood

Volumn 90, Issue 9, 1997, Pages 3496-3506

  Humeau, Laurent ^b   Chabannon, Christian ^b   Firpo, Meri T ^b   Mannoni, Patrice ^b   Bagnis, Claude ^b   Roncarolo, Maria Grazia ^b   Namikawa, Reiko ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; CD34 ANTIGEN; CD38 ANTIGEN;

ANIMAL TISSUE; ARTICLE; BONE MARROW; FETUS; FETUS LIVER; FLOW CYTOMETRY; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSDUCTION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROVIRUS; SCID MOUSE; THYMUS;

EID: 0030822347     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.9.3496     Document Type: Article

References (50)

1. Miller AD: Retroviral vectors. Curr Top Microbiol Immunol 158:1, 1992
2. Miller DG, Adam MA, Miller AD: Gene transfer by retrovirus vector occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 10:4239, 1990
3. Lerner C, Harrison DE: 5-fluorouracil spares hemopoietic stem cells responsible for long-term repopulation. Exp Hematol 18:114, 1990
4. Berardi AC, Wang A, Levine JD, Lopez P, Scadden DT: Functional isolation and characterization of human hematopoietic stem cells. Science 267:104, 1995
5. Ponchio L, Conneally E, Eaves C: Quantitation of the quiescent fraction of long-term culture-initiating cells in normal human blood and bone marrow and the kinetics of their growth-factor stimulated entry into S-phase in vitro. Blood 86:3314, 1995
6. Bodine DM, Karlsson S, Nienhuis AW: Combination of interleukins 3 and 6 preserves stem cell function in culture and enhances retrovirus-mediated gene transfer into hematopoietic stem cells. Proc Natl Acad Sci USA 86:8897, 1989
7. Lansdorp PM, Dragowska PM: Maintenance of hematopoiesis in serum-free bone marrow cultures involves sequential recruitment of quiescent progenitors. Exp Hematol 21:1321, 1993
8. hi human marrow cells after in vitro cytokine exposure. Blood 85:1480, 1995
9. Muench MO, Firpo MT, Moore MAS: Bone marrow transplantation with interleukin-1 plus kit-ligand ex vivo expanded bone marrow accelerates hematopoietic reconstitution in mice without the loss of stem cell lineage and proliferative potential. Blood 81:3463, 1993
10. Brugger W, Heimfeld S, Berenson RJ, Mertelsmann R, Kanz L: Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. N Engl J Med 333:283, 1995
11. Duménil D, Jacquemin-Sablon H, Neel H, Frindel E, Dautry F: Mock retroviral infection alters developmental potential of murine bone marrow stem cells. Mol Cell Biol 9:4541, 1989
12. Rebel VI, Lansdorp PM: Culture of purified stem cells from fetal liver results in loss of in vivo repopulating potential. J Hematother 5:25, 1996
13. + hematopoietic cell transduction with cell-free retroviral vector preparations. Proc Natl Acad Sci USA 92:4372, 1995
14. Brenner MK, Hill DR, Holladay MS, Heslop HE, Moen RC, Buschle M, Krance RA, Santana VM, French Anderson W, Ihle JN: Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients. Lancet 342:1134, 1993
15. + cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood 83:3068, 1994
16. Dunbar CE, Cottler-Fox M, O'Shaughnessy JA, Doren S, Carter C, Berenson R, Brown S, Moen RC, Greenblatt J, Stewart FM, Leitman SF, Wilson WH, Cowan K, Young NS, Nienhuis AW: Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood 85:3048, 1995
17. Bordignon C, Notarangelo LD, Nobili N, Ferrari G, Casorati G, Panina P, Mazzolari E, Maggiori D, Rossi C, Servida P, Ugazio AG, Mavilio F: Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients. Science 270:470, 1995
18. Kohn DB, Weinberg KI, Nolta JA, Heiss LN, Lenarsky C, Crooks GM, Hanley ME, Annett G, Brooks JS, El-Khoureiy A, Lawrence K, Wells S, Moen RC, Bastian J, William-Herman DE, Elder M, Wara D, Bowen T, Hershfield MS, Mullen CA, Blease RM, Parkman R: Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nature Med 1:1017, 1995
19. Nolta JA, Smogorzewska EM, Kohn DB: Analysis of optimal conditions for retroviral-mediated transduction of primitive human hematopoietic cells. Blood 86:101, 1995
20. Nolta JA, Dao MA, Wells S, Smogorzewska EM, Kohn DB: Transduction of pluripotent human hematopoietic stem cells demonstrated by clonal analysis after engraftment in immune-deficient mice. Proc Natl Acad Sci USA 93:2414, 1996
21. + cord blood cells is expressed by their T-cell progeny in the SCID-hu thymus. Blood 88:107, 1996
22. Larochelle A, Vormoor J, Hanenberg H, Wang JCY, Bhatia M, Lapidot T, Moritz T, Murdoch B, Xiao XL, Kato I, Williams DA, Dick J: Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy. Nature Med 2:1329, 1996
23. - progenitor cells. Blood 77:1218, 1991
24. - progenitor cells in long-term cultures and semisolid assays. Blood 81:2916, 1993
25. - cells in cord blood and bone marrow. Blood 86:3745, 1995
26. + human fetal liver progenitors with high proliferative potential. Blood 83:3170, 1994
27. Hao Q-L, Thiemaann FT, Petersen D, Smogorzewska EM, Crooks GM: Extended long-term culture reveals a high quiescent and primitive human hematopoietic progenitor population. Blood 88:3306, 1996
28. Agrawal YP, Agrawal RS, Sinclair AM, Young D, Maruyama M, Levine F, Ho AD: Cell-cycle kinetics and VSV-G pseudotyped retrovirus-mediated gene transfer in blood-derived CD34+ cells. Exp Hematol 24:738, 1996
29. Lansdorp PM, Dragowska W, Mayani H: Ontogeny-related changes in proliferative potential of human hematopoietic cells. J Exp Med 178:787, 1993
30. Lyman SD, James L, Vanden Bos T, de Vries P, Brasel K, Gliniak B, Hollingsworth LT, Picha KS, McKenna HJ, Splelt RR, Fleteher FA, Maraskovsky E, Farrah T, Foxworthe D, Williams DE, Beckmann MP: Molecular cloning of a ligand for the flt3/flk2 tyrosine kinase receptor: A proliferutive factor for primitive hematopoietic cells. Cell 75:1157, 1993
31. Hannum C, Culpepper J, Camphell D, McClanahan T, Zurawski S, Bazan JF, Kastelstein R, Hudak S, Wagner J, Mattson J, Luh J, Duda G, Martina N, Peterson D, Menon S, Shanafelt A, Muench M, Keiner G, Namikawa R, Rennick D, Roncarolo MG, Zlotnik A, Rosnet O, Dubreuil P, Birnbaum D, Lee F: Ligand for flt3/flk2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs. Nature 368:643, 1994
32. Muench MO, Roncarolo MG, Menon S, Xu Y, Kastelein R, Zurawski S, Hannum CH, Culpepper J, Lee F, Namikawa R: FLK2/FLT-3 ligand regulates the growth of early myeloid progenitors isolated from human fetal liver. Blood 85:963, 1995
33. Hudak S, Hunte B, Culpepper J, Menon S, Hannum C, Thompson-Snipes L, Rennick D: FLT3/FLK2 ligand promotes the growth of murine stem cells and the expansion of colony-forming cells and spleen colony-forming units. Blood 85:2747, 1995
34. - cells and maintains progenitor cells in vitro. Blood 87:3563, 1996
35. + progenitors to sustain long-term hematopoiesis in immune-deficient mice after ex vivo retroviral-mediated transaction. Blood 89:446, 1997
36. Namikawa R, Weilbaecher KN, Kaneshima H, Yee EJ, McCune JM: Long-term human hematopoiesis in the SCID-hu mouse. J Exp Med 172:1055, 1990
37. Kyoizumi S, Baum CM, Kaneshima H, McCune JM, Yee EJ, Namikawa R: Implantation and maintenance of functional human bone marrow in SCID-hu mice. Blood 79:1704, 1992
38. Di Giusto D, Chen S, Combs J, Webb S, Namikawa R, Tsukamoto A, Chen BP, Galy AH: Human fetal bone marrow early progenitors for T, B, and myeloid cells are found exclusively in the population expressing high levels of CD34. Blood 84:421, 1994
39. + cell populations and into TF-1 cells: Future prospects in gene therapy. Hum Gene Ther 5:1325, 1994
40. Ferry N, Duplessis O, Houssin D, Danos O, Heard JM: Retroviral-mediated gene tranfer into hepatocytes in vivo. Proc Natl Acad Sci USA 88:8377, 1991
41. Orlic D, Girard LJ, Jordan CT, Anderson SM, Cline AP, Bodine DM: The level of mRNA encoding the amphotropic retrovirus receptor in mouse and human hematopoietic stem cells is low and correlates with the efficiency of retrovirus transduction. Proc Null Acad Sci USA 93:11097, 1996
42. Huang S, Law P, Ho AD: Very primitive hematopoietic stem cells from fetal tissues, umbilical cord, adult bone marrow versus peripheral blood. Exp Hematol 24:1024, 1996 (abstr)
43. Lemischka IR, Raulet DH, Mulligan RC: Developmental potential and dynamic behavior of hematopoietic stem cells. Cell 45:917, 1986
44. Moritz T, Keller DC, Williams DA: Human cord blood cells as targets for gene transfer: Potential use in genetic therapies of severe combined immunodeficiency disease. J Exp Med 178:529, 1993
45. Vormoor J, Lapidot T, Larochelle A, Dick JE: Human hematopoiesis in SCID mice, in Roncarolo MG, Peault B, Namikawa R (eds): Human Hematopoiesis in SCID Mice. Austin, TX, RG Landes Co, 1995, p197
46. Pflumio F, Izac B, Katz A, Shultz LD, Vainchenker W, Coulombel L: Phenotype and function of human hematopoietic cells engrafting immune-deficient CB17-severe combined immunodeficiency mice and nonobese diabetic-severe combined immunodeficiency mice after transplantation of human cord blood mono nuclear cells. Blood 88:3731, 1996
47. Kyoizumi S, Murray LJ, Namikawa R: Preclinical analysis of cytokine therapy in the SCID-hu mouse. Blood 81:1479, 1993
48. Namikawa R, Ueda R, Kyoizumi S: Growth of human myeloid leukemias in the human marrow environment of SCID-hu mice. Blood 82:2526, 1993
49. Kay MA, Landen CN, Rothenberg SR: In vivo hepatic gene therapy: Complete albeit transient correction of factor IX deficiency in hemophilia B dogs. Proc Natl Acad Sci USA 91:2353, 1994
50. Challita PM, Kohn DB: Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo. Proc Natl Acad Sci USA 91:2567, 1994